RSS
|
Login
|
Register
Home
News
Latest News
People Moves
Business Briefs
Newsletters
Features
Features
Reprints
Issue Archive
Events
Awards
Webcasts
Surveys
Directories
PMD
MM&M Service Directory
Agency Gallery
Direct Marketing Showcase
Medical Education Review
Jobs
About Us
Subscriber Services
Contact Us
Media Information
Editorial Advisory Board
Drug Info
New Drug Dossier
Drug Database
Subscribe
Order Now
Subscriber Services
Newsletters
Home
>
Issue Archive
> March 2007 Issue of MMM
March 2007 Issue of MMM
Editor's Desk
Something for the weekend
As a young lad growing up in small-town England, my parents would insist that every six to eight weeks I visited the local barber for ...
Features
Headliner: Stan Woodland of CMI/Compas
Communications Media, Inc. founder Stan Woodland probably knows professional media buying and planning better than anyone, and he remains bullish on medical journal advertising.
The Highs and Lows in Cholesterol
Cholesterol drug marketers still say lower is better. Yet many in this $18 billion category are betting on a higher order of treatment.
Are NDA Laws Constitutional?
It will be an interesting month for the drug approval process, with Federal Circuit Court, FDA and Congress all considering whether terminally ill patients should ...
Maestros of Medical Advertising 2007
Last month three more marketing and publishing luminaries joined the elite ranks of the Medical Advertising Hall of Fame. Matthew Arnold chronicles the contributions of ...
A Day in the Life of Your Customer
Fly-on-the-wall observational techniques can reveal a range of information where traditional marketing research techniques often fall short. Barry J. Cerf looks at the benefits of ...
Antidote
Antidote
This month I’d like to take on a whopper: that drug companies have routinely withheld their expertise in HIV and life-saving treatments from the Third ...
Washington Insider
As I see it
Now come the ad police to ask for user fees from marketers. Admittedly, it’s just for TV ad previews, but the FDA’s Prescription Drug User ...
FDA responds positively to IOM report
FDA commissioner Andrew von Eschenbach on Jan. 30 unveiled a comprehensive series of steps now being undertaken in direct response to last September’s Institute of ...
Sens. Kennedy and Enzi present drug safety bill
Outgoing Senate Finance Committee chair Chuck Grassley (R-IA) has written HELP Committee leaders with a laundry list of FDA shortcomings that he hopes they will ...
Schering Sales Corp. to pay $435m in settlement
Schering Sales Corp., a division of Schering-Plough, will pay $435 million in connection with Medicaid fraud and illegal sales and marketing programs under a Jan. ...
FDA reveals $94m user fee increase
FDA drug and biologic user fees will jump almost 30% next year—from about $300 million to almost $400 million in 2008, according to details released ...
Cell Therapeutics reaches agreement with government
Cell Therapeutics has reached agreement with the federal government to pay $10.5 million to resolve the investigation of its business practices in marketing the cancer ...
Bayer settles with 30 states over Baycol marketing
Bayer has reached a settlement with 30 states to resolve a consumer protection enforcement action over the marketing of Baycol, a cholesterol-lowering drug withdrawn from ...
Public Citizen's Wolfe says Medtronic's DTC campaign is misleading
Public Citizen Health Research Group head Sidney Wolfe says Medtronic’s new DTC ad campaign on sudden cardiac arrest is highly misleading and tries to frighten ...
Genentech sends “dear doctor” letters
Genentech has sent a “dear doctor” letter to warn about a higher risk for stroke in patients taking 0.5 mg of Lucentis, indicated for treating ...
Woodcock named to new position at FDA
Janet Woodcock was named to a newly created position as FDA chief medical officer in a management reshuffle that brings in John Dyer to hold ...
Media Notepad
Quadrant purchase adds CME muscle
Quadrant HealthCom plans to beef up its med ed offering through four titles recently acquired from Jobson.
Publishers scrap over open access
An effort by scientific and medical publishers to push back against the “open access” movement ignited a spat in the pages of Nature magazine.
Macmillan names Elduff SVP of sales
Macmillan Medical Communications named Elsevier’s John Elduff SVP of sales.
Ingersoll forms Ingersoll Media Consulting
After 16 years as the in-house media maestro at Euro RSCG Life, Lisa Ingersoll is striking out on her own with Ingersoll Media Consulting.
Wiley & Sons acquires Carpe Diem Comms
John Wiley & Sons acquired Carpe Diem Communications, publisher of several food and drug-related titles including PFQ (Pharmaceutical Formulation & Quality), Contamination Control and Food ...
Gray named SVP for media strategy at InVentiv
Former FCB media chief Elizabeth Gray has been named SVP for media strategy at InVentiv Communications, a new group-wide position.
Media Forum
How directors master their domain
It can be overwhelming for directors to get their arms around the market while managing a media department.
CME Report
Instability in funding has medical schools nervous: report
Commercial CME funding for medical schools has increased appreciably over the last 12 years, through mid-2005, a new survey suggests.
Neurontin settlement funds education efforts
A Georgetown University Medical School professor recently launched a Web site offering links to non-commercially supported CME.
Bradshaw says firms shouldn't fear enforcement
Sheldon Bradshaw, FDA chief counsel, said firms shouldn’t fear enforcement if they disseminate a peer-reviewed journal article in a manner that complies with the safe ...
Davis challenges perceptions of didactic CME lectures
Dave Davis, MD, challenged the notion that didactic CME lectures don’t work, even though his body of research has shown that purely didactic talks don’t ...
CME improves docs: study
Studies suggest CME improves and maintains the knowledge, skills and performance of docs, said an AHRQ analysis.
Wuerth joins Curry Rockefeller Group
The Curry Rockefeller Group hired Laura Wuerth as director, account management.
CME Outfitters launches neuroscienceCME TV
CME Outfitters is launching neuroscienceCME TV, a one-hour, live and interactive CE activity broadcast via satellite, Webcast and telephone audioconference.
E-marketing
Summit addresses need for innovation
Pharmaceutical e-marketing experts called for more innovation in online efforts as the Web enters its second and third incarnations.
WebMD undergoes first overhaul since its launch
Web Watch
The ePharma Summit meeting in Philadelphia at the end of January confirmed just how hot the online health market is right now.
Direct Marketing
DMA names '07 pharma council chair
The Direct Marketing Association has named Dominque Hurley, VP and general manager for the Dendrite-owned relationship marketing firm Optas, as chairperson of its Pharmaceutical Marketing ...
Roska unit centers around healthcare
Roska Direct Advertising has restructured into three distinct units, including a rebranded healthcare advertising arm.
New River names new VP of sales
New River Pharmaceuticals named James Shaffer as VP of sales and marketing to oversee the anticipated launch of the company’s attention deficit-hyperactivity disorder (ADHD) drug ...
Eli Lilly asked to turn over Zyprexa promotion info
Eli Lilly has been asked by state prosecutors in Illinois and Vermont to turn over info about the way it promoted Zyprexa, its antipsychotic drug.
HealthEd adds new staff
HealthEd, a patient-education marketing firm, has added three new staff members.
Endo issued subpoena regarding Lidoderm promotion
Endo Pharmaceuticals was issued a subpoena by the Department of Health and Human Services regarding the promotion of its post-shingles pain patch Lidoderm, requesting documents ...
MicroMass hires marketing vets
MicroMass Communications, a relationship marketing firm, has hired marketing vets Dave Rockenbaugh and Gina Pettaris as associate creative directors, and James Pietz, as VP, interactive ...
DTC Report
King bets big on unbranded Bowl spots
King Pharmaceuticals courted controversy with its big bet on an unbranded disease awareness Super Bowl ad to drive sales of Altace.
Kessler, study get emotional over DTC
Emotional messaging trumps information in TV drug ads, according to a study published in the January/February 2007 issue of the Annals of Family Medicine.
Gardasil DTC driving force behind Merck expense increase
Gardasil DTC was the chief factor behind a 21% increase in Merck marketing and administrative expenses for the fourth quarter of 2006, followed by consumer ...
Digene launches TV spots
Digene, the maker of an HPV test, is piggybacking on Merck’s HPV awareness ads with TV spots of its own, which launched last month in ...
Wyeth CEO says industry's ED ads went overboard
Wyeth CEO Robert Essner told The Wall Street Journal that the industry went overboard with ED ads.
Companies waiting over a year to advertise newly approved drugs
Drug companies have been waiting an average of 15 months after approval to advertise drugs to consumers, according to TNS Media Intelligence.
Public Relations
Ferring courts sporting seniors for Euflexxa
Sports sponsorships and awareness campaigns aimed at seniors are staples of pharmaceutical communications.
Publicis picks up Sanofi vaccines PR
Sanofi Pasteur has handed the communications business on several key vaccines, including the prospective launch of Pentacel, to Publicis Public Relations.
In Focus
Congress eyes restrictions on DTC, med ed
The new Democratic Congress is living up to expectations with plenty of bicameral pharma-bashing rhetoric, but has so far failed to implement price controls and ...
Back Talk
Failure to communicate
In the classic 1967 movie, Cool Hand Luke, Paul Newman earns the respect of his fellow chain-gang prisoners by refusing to stay down after being ...
Most Popular
The End of CME as We Know It
Surprise! Massachusetts gift ban is back
Changing Channels
Abbott launches Crohn's disease podcasts
"Academic detailing" bill introduced
FDA cracks down on conflicts of interest in committees
Media Directors On the Spot
Bristol-Myers Squibb offers $4.5 billion for ImClone
Med Ed Review: From Regs, Few Riches
Headliner: Vertex's Craig Millian
Most Emailed
The End of CME as We Know It
Abbott launches Crohn's disease podcasts
Surprise! Massachusetts gift ban is back
Media Directors On the Spot
Changing Channels
FDA cracks down on conflicts of interest in committees
"Academic detailing" bill introduced
Bristol-Myers Squibb offers $4.5 billion for ImClone
Web Watch
Med Ed Review: From Regs, Few Riches
Most Recent
Abbott launches Crohn's disease podcasts
Doctors' Choice names top journal ads
FDA cracks down on conflicts of interest in committees
Surprise! Massachusetts gift ban is back
"Academic detailing" bill introduced
Bristol-Myers Squibb offers $4.5 billion for ImClone
Group calls for concise, user-friendly drug info
Verispan acquired by data rival SDI
FDA oversight limited on off-label promotion
American Heart Association CEO to retire
Popular Tags
Account wins & losses
Advertising
Agency
Approval
Awards
Biotech
Business
Consumer
Continuing medical education (CME)
Creative
Digital
Direct to patient (DTP)
FDA
Generic
Government
Legal
Marketing & Communications
Marketing Research
Media
Pharmaceutical
Professional
Promotion
Regulatory
Sales force
Suppliers & Vendors
Home
|
News
|
Features
|
Events
|
Surveys
|
Lists
|
Directories
|
Jobs
|
About Us
|
Contact Us
|
Subscribe
|
Newsletters
|
PMD
|
Advertise
|
Editorial Advisory Board
|
RSS